Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
The U.S. Food and Drug Administration on Thursday made recommendations to vaccine manufacturers for the virus strains to be ...
U.S. Health Secretary Robert F. Kennedy Jr. told food companies including PepsiCo and Kraft Heinz in a meeting on Monday that ...
The Trump Administration has eliminated two USDA food safety advisory committees that have been in place for decades. The U.S. Department of Agriculture ...
11hon MSN
Dr. Mehmet Oz, President Donald Trump's pick to lead the Centers for Medicare and Medicaid Services, will testify before the ...
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...
fraud and abuse related to the U.S. Food and Drug Administration.” Many of PhRMA’s member CEOs are scheduled to meet with President Donald Trump at the end of this week, according to a source ...
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
is pleased to announce today that the Company has provided its resubmission to the complete response amendment for its U.S. Food and Drug Administration ("FDA") new drug application for Ketamine, ...
The practice Kennedy is targeting, known as “generally recognized as safe” (GRAS), can occur when companies self-certify the safety of a food additive.
The Associated Press on MSN9d
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli LillyThe price cuts come as supplies improve. The U.S. Food and Drug Administration has moved both drugs off its list of medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results